The Henry C, Witelson Ocular Pathology Laboratory, McGill University, 3775 University St,, Room 216, Montreal, QC H3A 2B4, Canada.
BMC Ophthalmol. 2014 Feb 3;14:13. doi: 10.1186/1471-2415-14-13.
The treatment of uveal melanoma has seen a shift towards eye conserving treatments. Efforts have been made towards the identification of patients at high risk of metastatic disease with the use of prognostic fine needle biopsy, Monosomy 3 a risk factor for metastatic death thought to occur early in the development of uveal melanoma.
We report a case in which an atypical optic nerve lesion was found to be a peripapillary primary uveal melanoma with distinct non-pigmented and pigmented halves on gross dissection and corresponding disomy 3 and monosomy 3 halves. The tumour demonstrated rapid growth with apparent transformation from disomy 3 to monosomy 3.
These are clinical features that challenge the current concepts of the cytogenetic pathogenesis of uveal melanoma and demonstrate the potential problems and limitations of prognostic fine needle biopsy and molecular classifications.
葡萄膜黑色素瘤的治疗已经转向以保眼治疗为主。人们一直在努力通过使用预后性细针活检来识别患有转移性疾病风险高的患者,3 号单体是转移性死亡的风险因素,被认为在葡萄膜黑色素瘤的早期发展中就已经出现。
我们报告了一例典型视神经病变,大体解剖发现为沿神经分布的脉络膜黑色素瘤,具有明显的非色素性和色素性两半,相应的 3 号染色体三体和单体。肿瘤生长迅速,表现出从 3 号染色体三体到单体的明显转化。
这些临床特征对当前葡萄膜黑色素瘤细胞遗传学发病机制的概念提出了挑战,并表明预后性细针活检和分子分类的潜在问题和局限性。